94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Alfred Francis Attah1*
Adeshola Adebayo Fagbemi2
Olujide Olubiyi3,4
Hannah Dada-Adegbola5Akinseinde Oluwadotun6Anthony Elujoba7
Chinedum Peace Babalola2,8,9*- 1Department of Pharmacognosy and Drug Development, Faculty of Pharmaceutical Sciences, University of Ilorin, Ilorin, Nigeria
- 2Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria
- 3Department of Pharmaceutical Chemistry, Obafemi Awolowo University, Ile-Ife, Nigeria
- 4Institute of Biological Information Processing, Structural Biochemistry (IBI-7), Forschungszentrum Jülich, Jülich, Germany
- 5Department of Medical Microbiology and Parasitology, College of Medicine, University of Ibadan, Ibadan, Nigeria
- 6Nestle Nigeria Plc, Lagos, Nigeria
- 7Department of Pharmacognosy, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria
- 8Centre for Drug Discovery, Development and Production, University of Ibadan, Ibadan, Nigeria
- 9College of Basic Medical Sciences, Chrisland University, Abeokuta, Nigeria
A Corrigendum on
Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective
by Attah A. F., Fagbemi A. A., Olubiyi O., Dada-Adegbola H., Oluwadotun A., Elujoba A. and Babalola C. P. (2021). Front. Pharmacol. 12:596855. doi: 10.3389/fphar.2021.596855
In the original article, there was a mistake in Supplementary Table S1 as published. This table is totally missing; instead, Figure 7 (chemical structures 13–172) has been replaced here. Meanwhile, this same Figure 7 has incompletely been presented within the original article where only structures 13–23 appeared within the article without a link or statement directing readers to the remaining structures. The corrected Supplementary Table S1 appears below.
FIGURE 7
FIGURE 7. Structures of some plant-derived secondary metabolites with antiviral activities.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2021.721060/full#supplementary-material.
Keywords: COVID-19, phytomedicines, Traditional African Medicine, herbal immuno-stimulants, herb-drug interaction
Citation: Attah AF, Fagbemi AA, Olubiyi O, Dada-Adegbola H, Oluwadotun A, Elujoba A and Babalola CP (2021) Corrigendum: Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective. Front. Pharmacol. 12:721060. doi: 10.3389/fphar.2021.721060
Received: 05 June 2021; Accepted: 17 June 2021;
Published: 20 July 2021.
Edited and reviewed by:
Javier Echeverria, University of Santiago, ChileCopyright © 2021 Attah, Fagbemi, Olubiyi, Dada-Adegbola, Oluwadotun, Elujoba and Babalola. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Alfred Francis Attah, YWxmYXR0YWgyMDAwbmdAeWFob28uY29t; Chinedum Peace Babalola, cGVhY2ViYWJAZ21haWwuY29t